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Summary 
The binding of ~2SI-labelled human choriogonadotropin,  formation of cyclic 
adenosine 3 ' ,5 ' -monophosphate  (cyclic AMP), and synthesis of progesterone 
were examined in ovarian cells from immature rats. Collagenase dispersed ovarian 
cells were found to respond specifically to lutropin-like activity. The equilibrium 
dissociation constant  (Ko) for the binding of ~2SI-labelled choriogonadotropin was 
1.7 • 10 -l° M. Progesterone synthesis was increased at least 40-fold and cyclic 
AMP formation 10-fold in response to maximum hormonal  stimulation. The 
concentrat ion of choriogonadotropin which stimulated progesterone synthesis 
maximally in Eagle's minimum essential medium -- 0.1% gelatin (2 ng/ml), re- 
sulted in minimal (less than 30% of maximum} increases in cyclic AMP accumu- 
lation and hormone binding. Similarly, binding of chor iogonadotropin  was not  
saturated at a hormone  concentra t ion (50 ng/ml) that  stimulated maximal cyclic 
AMP formation.  These results are consistent with the existence of receptor  
reserve in the ovarian cell. A marked shift in the dose vs. response relationship 
for progesterone synthesis occurred when fetal calf serum was used to supple- 
ment  Eagle's minimum essential medium, however. Under these experimental  
conditions, progesterone synthesis reached a maximum at a hormone concen- 
tration of  the same order  of  magnitude as did cyclic AMP formation.  It is con- 
cluded that  the degree of  spare receptor  effect  observed may depend not  only 
on an absolute amount  of  excess receptor ,  but  also on the readiness of the 
system to respond in a given fashion. 
* To whom correspondence should be addressed. 
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Introduction 
The widespread disparity between the concentration of effector which can 
produce maximum specific binding to a cell and the lower concentration which 
maximally stimulates a cellular response, has had significant impact on theories 
of effector-target cell interaction (for a review, see ref. 1). The term "spare re- 
ceptor" has been used to describe the entities responsible for the binding which 
occurs after the response parameter has been saturated [2]. Spare receptors 
have been described for drugs [2,3] and polypeptide hormones including corti- 
cotropin [4,5], thyrotropin [6], follitropin [7] and lutropin or choriogonado- 
tropin [8--11]. In the testicular system, a disparity between the concentration 
of ~2SI-labelled choriogonadotropin required to saturate all the available binding 
sites and that  required for maximally stimulating cyclic AMP and testosterone 
accumulation has been reported [10]. 
Since the ovarian steroidogenic response to gonadotropin is also mediated by 
cyclic AMP [12,13], this study was undertaken to investigate the concentration 
dependence of choriogonadotropin binding, cyclic AMP production and proges- 
terone formation. 
Materials 
Minimum essential medium with Earle's salts and 10% fetal calf serum was 
supplied by Grand Island Biological Co. Purified pigskin gelatin was purchased 
from Eastman. Cyclic [~H]AMP (16 Ci/mmol) was obtained from Schwarz- 
Mann and [8-~4C]adenine (50--60 Ci/mol) from New England Nuclear. Deoxy- 
ribonucelase I (DNAase), Dowex 50-WX4 (200--400 mesh, H ~ form), cyclic 
AMP and bovine serum albumin fraction V were the products of Sigma Chemi- 
cal Co. Somatotropin, prolactin, thyrotropin and lutropin (NIH-LH-S18) were 
made available by the Hormone Distribution Program, National Institutes of 
Health. Purified human choriogonadotropin (11500 I.U./mg), as well as 125I- 
labelled choriogonadotropin (50 Ci/pg) and reagents for progesterone radio- 
immunoassay were provided by Dr. A.R. Medgley, Jr. of this university. Lutro- 
pin (LER 1705) was a gift from Dr. Leo. E. Reichert, Jr. of Emory Univeristy, 
Atlanta, Ga. Aldrich Chemical Co. supplied 1-methyl-3-isobutylxanthine. 
Sprague-Dawley rats were purchased from Spartan Farms, Hazlett, Mich. Col- 
lagenase (Type CLS) was the product of Worthington Biochemical Corp. 
Methods 
Cell suspension. Cells were prepared from the ovaries of 25--26-day-old rats 
by a modification of the previously described procedure [14]. All manipula- 
tions were carried out in plastic or siliconized glass vessels. After excision, 
ovaries were placed in minimal essential medium supplemented with 10% fetal 
calf serum, or for the experiments shown in Figs. 2 and 3, with 0.1% pigskin 
gelatin. They were then trimmed of excess fat, weighed and quartered into 
minimal essential medium with approx. 500 units/ml collagenase and 0.4 mg/ 
100 ml DNAase at 50 mg tissue per ml. The minced tissue was digested at 37°C 
under O2/CO2 (95 : 5, v/v) with shaking for 2 h. Mechanical dispersal was pro- 
vided by pipetting the suspension up and down in a needleless 1 ml plastic 
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syringe 30 times at 30, 60 and 120 min of incubation. The cells were then cen- 
trifuged at room temperature at 600 X g for 3 min and resuspended in fresh 
medium. Two additional washes were performed. The cells were finally resus- 
pended in medium at 50 mg original wet weight of tissue per ml, which gave 
approx. 3 • l 0  T cells per ml. Cells were counted in a hemocytometer  and via- 
bility determined by dye exclusion following staining in 0.02% nigrosin. DNA 
was estimated by the method of Burton [15] for corrections for differences in 
cell yields between experiments. However, such corrections did not materially 
alter the results, since the yield routinely varied by less than 5%. The number 
of replicate experiments, each performed in duplicate, is given in parentheses 
in the figure legends. 
Cyclic AMP measurements. Approx. 3 • 106 cells in 0.1 ml of cell suspension 
was incubated at 37°C for 30 min {unless stated otherwise) under O2/CO2 
(95 : 5, v/v) in a final volume of 300 pl with or without  test substances. The 
1-methyl-3-isobutylxanthine was present unless stated otherwise, at 0.5 mM to 
inhibit cyclic AMP degradation (1-methyl-3-isobutylxanthine did not  alter the 
position of the dose vs. response curve for cyclic AMP; data not shown). For 
studying the incorporation of ['4C] adenine into cyclic ['4C] AMP, the prelabel- 
ling technique was employed [16,17,19]. After a preincubation period of 45 
min in the presence of 3.3 pCi/ml of [ '4C]adenine, the cells were centrifuged 
as above and resuspended in fresh medium for the test incubations. At the end 
of the test incubations, 0.2 ml of cold 10% trichloroacetic acid containing 
cyclic [3H]AMP {10000 cpm) for determination of recovery and carrier cyclic 
AMP (0.1 mmol) was added. The precipitated protein was removed by centri- 
fugation at 5000 X g for 10 min. The supernatant was freed of trichloroacetic 
acid by three extractions with 1 ml of ethyl ether each time, and placed on a 
Dowex 50W column (0.6 X 4 cm) [19]. This column was eluted with 2.5 ml of 
water and the eluate containing labelled ATP and ADP discarded. An additional 
3 ml water wash was performed and to this eluate was added 0.3 ml each of 
0.125 M ZnSO4 and 0.125 M Ba(OH)2 on ice. After 10 min the BaSO4 precipi- 
tate was removed by centrifugation at 2000 X g for 10 min and a 2 ml aliquot 
of the supernatant counted. The scintillation fluid contained 50 mg POPOP (p- 
bis-[2-(5-phenyloxazolyl)]-benzene), 4 g PPO (2,5~liphenyloxazole), 500 ml of 
Triton X-100, and 500 ml of toluene. Single determinations were made on 
duplicate samples for each experiment. Alternatively, the mass of cyclic AMP 
formed was determined by trichloroacetic acid extraction and protein binding 
assay as described by Gilman [20] and modified by Brooker [21]. Two deter- 
minations were performed on replicate 20-pl aliquots of duplicate samples for 
each experiment. 
Determination of  progesterone accumulation. Cells were incubated as de- 
scribed above for cyclic AMP measurements, with the exception that  1-methyl- 
3-isobutylxanthine was not  present. Following incubation (for 2 h, unless 
otherwise noted) the reaction was stopped by placing the sample tubes in a 
boiling water bath for 3 min, after which the precipitated protein was removed 
by centrifugation at 4°C for 10 min at 5000 X g. The supernatants were frozen 
at --20°C for later assay in duplicate of 10- and 25°pl aliquots by the radio- 
immunoassay described by Bajpai et al. [14] using an antiserum characterized 
by Niswender [22]. In brief, appropriate standards or samples were incubated 
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for 16 h in buffer (0.14 M NaCI, 0.01 M sodium phosphate,  and 1 : 10 000 mer- 
thiolate at pH 7.0) with approx. 30000 cpm of tracer and progesterone anti- 
serum (at a final dilution of 1 : 16000).  The tracer was the carbon-11 tyrosine 
methyl  ester derivative of progesterone which had been iodinated with ~2sI. The 
antiserum was similarly raised against a protein conjugate with progesterone 
attached to protein via the ca r bon - l l  position. The first incubation was fol- 
lowed by a second 16 h incubation with anti-rabbit 7-globulin (1 : 90 final dilu- 
tion) and the final precipitate collected by centrifugation at 1500 × g for 30 
min. The precipitates were counted directly with a Searle Gamma Counter 
Model 1195. Analysis of the radioimmunoassay data was made utilizing the 
computer  program described by Duddleson et al. [30] or using a Wang Pro- 
gramable Calculator, Model 600-6. 
Measurement o f  ~2SI-labelled choriogonadotropin binding. Binding of gonad- 
otropin to ovarian cells was determined by a modification of the assay of 
Cuatrecasas [31] for insulin binding to fat cells. Ovarian cells were incubated as 
above with ~2SI-labelled choriogonadotropin in test tubes which had been pre- 
coated with 5% bovine serum albumin. Binding was terminated at the desired 
times by dilution (3 : 1) with cold medium and immediate centrifugation at 
4°C for 3 min at 500 X g. The medium was removed and the pelleted cells 
washed twice with 1 ml of fresh media and counted directly on a gamma 
counter  (Searle Analytic, Model 1195). Specific binding was calculated by cor- 
recting for binding in the presence of greater than a 1000-fold excess of unla- 
belled hormone (non-specific binding), with both  specific and non-specific 
binding assays performed in duplicate or quadruplicate. Non-specific binding 
was generally less than 10% of the total binding. 
Calculation o f  the specific activity o f  '2SI-labelled choriogonaclotropin. The 
specific activity of the '2SI-labelled chor iogonadotropin  was calculated from 
the quanti ty of  radioactivity recovered with protein following iodination (A.R. 
Midgley, Jr., personal communicat ion)  and corrected for the fact that  only 
approx. 60% of this radioactivity would bind to plasma membranes from 
bovine corpora lutea (determined in our laboratory)  or from rat ovaries (J. 
Duncan, personal communicat ion) .  Alternatively, the specific activity was 
measured by comparison of the displacement of a trace amount  of  '2SI-labelled 
choriogonadotropin from rat ovarian cells by 12~I-labelled choriogonadotropin 
(self-displacement), with the displacement by unlabelled hormone (Midgley, 
Jr., A.R., personal communicat ion) .  
Determination o f  equilibrium dissociation constant. The binding of 12Sl-la- 
belled choriogonadotropin was carried out  as described above. The free hor- 
mone concentrat ion was calculated by correcting the total quanti ty added for 
that bound both specifically and non-specifically, and for the fact that  only 
60% of the radioactivity could be bound. The bound hormone was calculated 
from the radioactivity bound,  with no correction necessary for inactive hor- 
mone. Analysis of  the bound to free ratio as a function of  the bound hormone 
was made by a Sdatchard plot [23],  as described by Birnbaumer et al. | 24[ .  
Results  
Characterization o f  cell suspension 
Preparation of cells by the technique described here produced a similar via- 
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bility, as determined by nigrosin exclusion, as that  previously reported from 
this laboratory [ 18]. The yield and responsiveness to hormone were more con- 
sistent with the mild collagenase treatment used in these studies. In fact, the 
minimum concentration of choriogonadotropin (50 pg/ml) which produced a 
detectable increase in progesterone synthesis was comparable to that  which 
elicited a similar response in the sensitive mouse Leydig cell preparation [25] 
The amount  of DNA per cell, 7.6 +- 0.5 pg, agreed with values reported by 
Liu and Gorski [26] for a cell suspension of rabbit ovaries. 
Ovarian cells responded specifically to lutropin-like activity. Those samples 
with lutropin-like activity (lutropin and choriogonadotropin) produced maxi- 
mal increases over control values. Somatotropin and prolactin did not stimulate 
progesterone synthesis nor did insulin (data not shown}. 
Time course of  12SI-labelled choriogonadotropin binding, cyclic [~4C]AMP for- 
mation and progesterone synthesis 
As shown in Fig. 1 the formation of cyclic [~4C]AMP in the presence of 0.5 
mM 1-methyl-3-isobutylxanthine was immediate and marked, rising to a value 
approx. 10-fold over controls in 15 min. Control values increased only slightly 
even though phosphodiesterase inhibitor was included in the incubation. Deter- 
mination of the mass of cyclic AMP generated showed a similar 10-fold increase 
in the presence of 0.5 mM 1-methyl-3-isobutylxanthine. In the absence of 1- 
methyl-3-isobutylxanthine, a smaller increase in cyclic AMP was observed. Pro- 
gesterone synthesis in the absence of 1-methyl-3-isobutylxanthine, on the other 
hand, increased less rapidly, but rose steadily and at an approximately linear 
rate for 60 rain {Fig. 1). 
The time course of ~2SI-labelled choriogonadotropin binding of ovarian cells 
revealed that  hormone binding approached equilibrium after 1 h of incubation, 
similar to choriogonadotropin binding to testis receptor [9].  Unlabelled chorio- 
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Fig.  1. T ime  c o u r s e  o f  c y c l i c  [ 14 C ] A M P  f o r m a t i o n  a n d  p r o g e s t e r o n e  s y n t h e s i s .  O v a r i a n  ce l l s  w e r e  i n c u -  
b a t e d  as  d e s c r i b e d  in  M e t h o d s  w i t h o u t  (o,A) a n d  w i th  (o,A) 67  n g / m l  c h o r i o g o n a d o t r o p i n .  C y c h c  [ 1 4 C ] .  
AMP (A,4) [4 ]  a n d  p r o g e s t e r o n e  ( o , e )  [2 ]  w e r e  a s s a y e d  at  t h e  i n d i c a t e d  t imes .  
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40 ng/ml. The equilibrium dissociation constant,  calculated from the graphical 
t reatment  of  the above data according to Scatchard [23],  was 1.7 • 10 -~° M 
(Fig. 2). 
Effect of  hormone concentration on choriogonadotropin binding, cyclic AMP 
formation and progesterone synthesis 
The concentrat ion dependence of ~2SI-labelled choriogonadotropin binding, 
cyclic AMP product ion and progesterone synthesis is shown in Fig. 3. This 
exper iment  was performed in minimal essential medium using 0.1% gelatin as 
a protein substitute for fetal calf serum. Gelatin was used in order to achieve a 
chemically defined medium. The time course for ~25I-labelled choriogonado- 
tropin binding, cyclic [~4C]AMP formation,  and progesterone synthesis were 
unchanged in this medium compared to that  supplemented with fetal calf 
serum (data no t  shown). The disparity between the binding, cyclic AMP and 
progesterone curves was striking. Measurement of  cyclic AMP by the protein 
binding method did not  alter these results (data not  shown). There was a 20- 
fold difference between the concentrat ions of choriogonadotropin required 
to cause half maximal stimulation of cyclic AMP and progesterone accumula- 
tion. A lesser separation existed between the dose respone curves for the 12sI- 
labelled chor iogonadotropin  binding and cyclic AMP accumulation. 
When the concentra t ion dependence of the above parameters was deter- 
mined in minimum essential medium-fetal calf serum, however, somewhat  dif- 
ferent results were obtained (Fig. 4). The curves for  hormone binding and cy- 
clic AMP formation were not  shifted. However, the concentrat ion of chorio- 
gonadotropin which produced 50% of the maximum response on the progester- 
one curve had shifted from 0.2 to 0.7 ng/ml. This effect  was reproducible and 
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Fig .  2. D i s p l a c e m e n t  o f  1 2 5 i . l a b e l l e d  c h o r i o g o n a d o t r o p i n  b y  u n l a b e l l e d  e h o r i o g o n a d o t r o p i n .  Cei ls  w e r e  
i n c u b a t e d  w i t h  2 0 0 0 0 0  c p m  (3 .3  n g )  o f  l 25 I - l abe l l ed  c h o r i o g o n a d o t r o p i n  in  t h e  p r e s e n c e  o f  t h e  i n d i c a t e d  
c o n c e n t r a t i o n  o f  u n l a b e n e d  h o r m o n e .  I n c u b a t i o n s  w e r e  c a r r i e d  o u t  f o r  1 h i n  q u a d r u p l i c a t e .  S p e c i f i c  
b i n d i n g  w a s  c a l c u l a t e d  b y  c o r r e c t i n g  t o t a l  b i n d i n g  f o r  c o u n t s  b o u n d  in  a l O O 0 - f o l d  e x c e s s  o f  u n l a b e l l e d  
c h o r i o g o n a d o t r o p i n  [1 ].  R e s u l t s  a re  t h e  m e a n  t S .E .  
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Fig. 3 .  125  I-labelled c h o r i o g o n a d o t r o p i n  b ind ing ,  cycl ic  [ 14 C] AMP f o r m a t i o n  an d  p roges t e rone  synthes is  
in m i n i m u m  essential  m e d i u m - g e l a t i n  as a f u n c t i o n  of  c h o r i o g o n a d o t r o p i n  c o n c e n t r a t i o n .  Ovar ian  cells 
were  i n c u b a t e d  in m i n i m u m  essential  m e d i u m - 0 . 1 %  gelat in in the  presence  of 50 p g /ml  to  500 n g /ml  of  
un labe l led  c h o r i o g o n a d o t r o p i n  and cylic [ 1 4 C ] A M P  f o r m a t i o n  (o) [2]  and  p roges t e rone  synthes is  ( e )  
[2]  were  m e a s u r e d  as descr ibed  in Methods.  Binding of  125i . label led  c h o r i o g o n a d o t r o p i n  was also mea -  
sured at  the ind ica ted  c o n c e n t r a t i o n s  of  label led h o r m o n e  (A) [2] .  
t e rone  levels w i t h o u t  an e f f e c t  on  basal levels.  A n o t h e r  change  in the  proges-  
t e rone  curve was  that  it a p p r o a c h e d  a m a x i m u m  at a h o r m o n e  c o n c e n t r a t i o n  
o f  the  same order  o f  magn i tude  as that  for  m a x i m u m  binding and cyc l ic  AMP 
f o r m a t i o n .  The  presence  o f  fetal  calf  s erum appears to  increase  the  upper l imit  
on  p r o g e s t e r o n e  p r o d u c t i o n ,  a l lowing  c lose  but  non- l inear  corre lat ion  o f  ste- 
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Fig. 4. 1 2 5 i . label led  c h o r i o g o n a d o t r o p i n  b inding,  cyclic [14C]  AMP f o r m a t i o n ,  and  p roges t e rone  syn the -  
sis in response  to  c l i o r i ogona do t rop in  in m i n i m u m  essential  m e d l u m - f e t a l  calf  s e rum.  Ovar ian cells were 
exposed  to  d i f f e r en t  c o n c e n t r a t i o n s  of  un labe l led  c h o r i o g o n a d o t x o p i n  in m e d i u m  con ta in ing  10% fetal  
calf s e r u m .  Cyclic [ 1 4 C ] A M P  f o r m a t i o n  (A) [3]  a nd  p r o g e s t e r o n e  synthes is  (o)  [4] were  m e a s u r e d  as de- 
scr ibed  in Methods .  Binding of  1 2 51 at the  c o n c e n t r a t i o n s  of  label led h o r m o n e  s h o w n  was also m e a s u r e d  
(u)  [3 ] .  
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T A B L E  I 
T H E  E F F E C T  O F  1 - M E T H Y L - 3 - I S O B U T Y L X A N T H I N E  ON P R O G E S T E R O N E  S Y N T t t E S I S  
Cel l s  were  i n c u b a t e d  as d e s c r i b e d  in  M e t h o d s  w i t h  0 .5  M 1 - m e t h y l - 3 - i s o b u t y [ x a n t h i n e  or  6.7 n g / m l  
c h o r i o g o n a d o t r o p i n .  The  u n t r e a t e d  c o n t r o l  p r o g e s t e r o n e  leve l  was  9 0  ( 8 3 - - 9 7 )  p g / p g  D N A  ( m e a n  a n d  
r ange  o f  d u p l i c a t e s )  a t  ze ro  t i m e .  
T i m e  P r o g e s t e r o n g  ( p g / p g  D N A )  
( ra in )  
1 -Me thy l -3 -  C h o r i o g o n a d o t r o p i n  
i s o b u t  y l x a n t h i n e  
15  208-+  15 198  ( 1 9 0  2 0 6 )  
30  247  -+ 3 2 8 2  ( 2 6 0 - - 3 0 4 )  
60  285-+ 8 4 4 3  ( 3 8 4 - - 5 0 2 )  
roidogenesis with cyclic AMP formation over a wider range of hormone con- 
centrations. A close correlation between gonadotropin binding and progester- 
one production has been reported under similar experimental conditions [32]. 
Also consistent with the result that  small increases in cyclic AMP formation 
give rise to substantial increases in progesterone production, was the effect of 
1-methyl-3-isobutylxanthine on progesterone synthesis. Slight increases in cy- 
clic AMP formation due to the presence of 1-methyl-3-isobutylxanthine alone 
produced progesterone synthesis nearly equal to that  of choriogonadotropin 
alone (Table I) up to 30 min of incubation. 
Discussion 
These experiments were designed to utilize a cell suspension system to corre- 
late on a time and concentration basis, the binding of choriogonadotropin with 
cyclic AMP production and progesterone synthesis. Choriogonadotropin bind- 
ing and cyclic AMP formation occurred rapidly, followed by progesterone syn- 
thesis, consistent with the second messenger role for cyclic AMP. It was found 
that wide disparities existed between the concentration vs. effect curves for 
hormone binding, cyclic AMP production and progesterone synthesis in chemi- 
cally defind medium. Stimulation of progesterone synthesis had reached a 
maximum at concentrations of choriogonadotropin which elicited minimal in- 
creases in choriogonadotropin binding or cyclic AMP formation. This phenome- 
non of disparity between concentration effect curves for binding and cyclic 
AMP production and/or endpoint response has been reported for a number of 
hormonally responsive systems [ 3--11 ]. 
One possible explanation for the results is the theory that  excess or spare 
receptors exist, which may not be coupled to adenylate cyclase and/or steroid- 
ogenesis [1--10]. Such spare receptors could account for the small (2-fold), but 
consistently observed difference, between the choriogonadotropin binding and 
cyclic AMP formation dose vs. response relationships. Alternatively, formation 
of cyclic AMP may be controlled by a feedback regulator [27], which could 
prevent activation of adenylate cyclase by all the occupied receptors. 
The results obtained in minimum essential medium supplemented with fetal 
calf serum, however, support the alternative explanation. The fact that  the ob- 
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served disparity between cyclic AMP formation and progesterone synthesis was 
lessened when the cells were exposed to a variety of anabolic stimuli found in 
serum, supports the hypothesis that  such disparities are caused by other factors 
such as available concentrations of substrates, cofactors, activators or inhibitors 
involved the cascade of reactions leading from binding to physiological re- 
sponse [4,8]. The importance of NADPH, for instance, in the synthesis of pro- 
gesterone has been demonstrated with rabbit ovarian homogenates [28]. Alter- 
natively, since it is known that  progesterone is metabolized rapidly to other 
steroids, fetal calf serum may exhibit a protecting effect by inhibiting this pro- 
cess [29]. Thus all of the receptors may be coupled to cellular events, but the 
response elicited by that  coupling is dependent upon the cell's ability to act. 
This readiness, as expressed by intracellular levels of substrates, intermediates 
and the like, could in turn be controlled by serum factors, thus establishing a 
new level of  control beyond that  of gonadotropin or receptor concentration 
alone. 
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